MAJOR CATALYST

PTE has potential major catalysts next week: earnings reporting and toppling data for diabetic foot ulcer trials

Last time people thought they might give trial data at conference (in January i believe) stock was up 100%ish

If they do report the data and its positive expect it to go much higher

Completion of Enrollment in Diabetic Foot Ulcer Randomized Controlled Trial

On January 21, 2021 PolarityTE announced it has completed target enrollment of 100 subjects in a randomized controlled trial (RCT) evaluating SkinTE plus standard of care (SOC) versus SOC alone for the treatment of diabetic foot ulcers (DFUs) and plans to report topline data via press release and presentation at the Symposium on Advanced Wound Care (SAWC) Spring 2021 to be held May 12-16, 2021, barring any unforeseen scheduling or other disruptions due to COVID-19. The Company believes this trial will provide supporting data that can be incorporated into its IND application.